English
简体中文
Total: £ 56.28
Published Date: 2024-09-13 | Pages: 99 | Tables: 200 | Pharma & Healthcare
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
The global market for Sufentanil (API) was estimated to be worth US$ 302 million in 2023 and is forecast to a readjusted size of US$ 523.9 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Sufentanil is a powerful analgesic drug with broad application prospects in the fields of medical services and drug therapy. In the next few years, the market size of sufentanil injection is expected to continue to expand and become an important pillar in the field of medical services and drug treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sufentanil (API), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sufentanil (API) by region & country, by Type, and by Application.
The Sufentanil (API) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sufentanil (API).
Market Segmentation
By Company
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
Segment by Type:
Purity 98%
Purity 99%
Segment by Application
Injection
Capsule
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sufentanil (API) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Sufentanil (API) Product Introduction
1.2 Global Sufentanil (API) Market Size Forecast
1.2.1 Global Sufentanil (API) Sales Value (2019-2030)
1.2.2 Global Sufentanil (API) Sales Volume (2019-2030)
1.2.3 Global Sufentanil (API) Sales Price (2019-2030)
1.3 Sufentanil (API) Market Trends & Drivers
1.3.1 Sufentanil (API) Industry Trends
1.3.2 Sufentanil (API) Market Drivers & Opportunity
1.3.3 Sufentanil (API) Market Challenges
1.3.4 Sufentanil (API) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sufentanil (API) Players Revenue Ranking (2023)
2.2 Global Sufentanil (API) Revenue by Company (2019-2024)
2.3 Global Sufentanil (API) Players Sales Volume Ranking (2023)
2.4 Global Sufentanil (API) Sales Volume by Company Players (2019-2024)
2.5 Global Sufentanil (API) Average Price by Company (2019-2024)
2.6 Key Manufacturers Sufentanil (API) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sufentanil (API) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sufentanil (API)
2.9 Sufentanil (API) Market Competitive Analysis
2.9.1 Sufentanil (API) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sufentanil (API) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sufentanil (API) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 98%
3.1.2 Purity 99%
3.2 Global Sufentanil (API) Sales Value by Type
3.2.1 Global Sufentanil (API) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sufentanil (API) Sales Value, by Type (2019-2030)
3.2.3 Global Sufentanil (API) Sales Value, by Type (%) (2019-2030)
3.3 Global Sufentanil (API) Sales Volume by Type
3.3.1 Global Sufentanil (API) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sufentanil (API) Sales Volume, by Type (2019-2030)
3.3.3 Global Sufentanil (API) Sales Volume, by Type (%) (2019-2030)
3.4 Global Sufentanil (API) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Injection
4.1.2 Capsule
4.2 Global Sufentanil (API) Sales Value by Application
4.2.1 Global Sufentanil (API) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sufentanil (API) Sales Value, by Application (2019-2030)
4.2.3 Global Sufentanil (API) Sales Value, by Application (%) (2019-2030)
4.3 Global Sufentanil (API) Sales Volume by Application
4.3.1 Global Sufentanil (API) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sufentanil (API) Sales Volume, by Application (2019-2030)
4.3.3 Global Sufentanil (API) Sales Volume, by Application (%) (2019-2030)
4.4 Global Sufentanil (API) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sufentanil (API) Sales Value by Region
5.1.1 Global Sufentanil (API) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sufentanil (API) Sales Value by Region (2019-2024)
5.1.3 Global Sufentanil (API) Sales Value by Region (2025-2030)
5.1.4 Global Sufentanil (API) Sales Value by Region (%), (2019-2030)
5.2 Global Sufentanil (API) Sales Volume by Region
5.2.1 Global Sufentanil (API) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sufentanil (API) Sales Volume by Region (2019-2024)
5.2.3 Global Sufentanil (API) Sales Volume by Region (2025-2030)
5.2.4 Global Sufentanil (API) Sales Volume by Region (%), (2019-2030)
5.3 Global Sufentanil (API) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sufentanil (API) Sales Value, 2019-2030
5.4.2 North America Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sufentanil (API) Sales Value, 2019-2030
5.5.2 Europe Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sufentanil (API) Sales Value, 2019-2030
5.6.2 Asia Pacific Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sufentanil (API) Sales Value, 2019-2030
5.7.2 South America Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sufentanil (API) Sales Value, 2019-2030
5.8.2 Middle East & Africa Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sufentanil (API) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sufentanil (API) Sales Value
6.2.1 Key Countries/Regions Sufentanil (API) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sufentanil (API) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sufentanil (API) Sales Value, 2019-2030
6.3.2 United States Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sufentanil (API) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sufentanil (API) Sales Value, 2019-2030
6.4.2 Europe Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sufentanil (API) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sufentanil (API) Sales Value, 2019-2030
6.5.2 China Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sufentanil (API) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sufentanil (API) Sales Value, 2019-2030
6.6.2 Japan Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sufentanil (API) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sufentanil (API) Sales Value, 2019-2030
6.7.2 South Korea Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sufentanil (API) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sufentanil (API) Sales Value, 2019-2030
6.8.2 Southeast Asia Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sufentanil (API) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sufentanil (API) Sales Value, 2019-2030
6.9.2 India Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sufentanil (API) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Kern Pharma
7.1.1 Kern Pharma Company Information
7.1.2 Kern Pharma Introduction and Business Overview
7.1.3 Kern Pharma Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Kern Pharma Sufentanil (API) Product Offerings
7.1.5 Kern Pharma Recent Development
7.2 Cambrex
7.2.1 Cambrex Company Information
7.2.2 Cambrex Introduction and Business Overview
7.2.3 Cambrex Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Cambrex Sufentanil (API) Product Offerings
7.2.5 Cambrex Recent Development
7.3 Hameln Rds
7.3.1 Hameln Rds Company Information
7.3.2 Hameln Rds Introduction and Business Overview
7.3.3 Hameln Rds Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Hameln Rds Sufentanil (API) Product Offerings
7.3.5 Hameln Rds Recent Development
7.4 Cristalia
7.4.1 Cristalia Company Information
7.4.2 Cristalia Introduction and Business Overview
7.4.3 Cristalia Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cristalia Sufentanil (API) Product Offerings
7.4.5 Cristalia Recent Development
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Information
7.5.2 Janssen Pharmaceuticals Introduction and Business Overview
7.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Janssen Pharmaceuticals Sufentanil (API) Product Offerings
7.5.5 Janssen Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Sufentanil (API) Industrial Chain
8.2 Sufentanil (API) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sufentanil (API) Sales Model
8.5.2 Sales Channel
8.5.3 Sufentanil (API) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Sufentanil (API) Market Trends
Table 2. Sufentanil (API) Market Drivers & Opportunity
Table 3. Sufentanil (API) Market Challenges
Table 4. Sufentanil (API) Market Restraints
Table 5. Global Sufentanil (API) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Sufentanil (API) Revenue Market Share by Company (2019-2024)
Table 7. Global Sufentanil (API) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Sufentanil (API) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Sufentanil (API) Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Sufentanil (API) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Sufentanil (API) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Sufentanil (API)
Table 13. Global Sufentanil (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sufentanil (API) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sufentanil (API) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Sufentanil (API) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Sufentanil (API) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Sufentanil (API) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Sufentanil (API) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Sufentanil (API) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Sufentanil (API) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Sufentanil (API) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Sufentanil (API) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Sufentanil (API) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Sufentanil (API) Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Sufentanil (API) Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Sufentanil (API) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Sufentanil (API) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Sufentanil (API) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Sufentanil (API) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Sufentanil (API) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Sufentanil (API) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Sufentanil (API) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Sufentanil (API) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Sufentanil (API) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Sufentanil (API) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Sufentanil (API) Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Sufentanil (API) Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Sufentanil (API) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Sufentanil (API) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Sufentanil (API) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Sufentanil (API) Sales Value by Region (2019-2024) & (%)
Table 44. Global Sufentanil (API) Sales Value by Region (2025-2030) & (%)
Table 45. Global Sufentanil (API) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Sufentanil (API) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Sufentanil (API) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Sufentanil (API) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Sufentanil (API) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Sufentanil (API) Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Sufentanil (API) Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Sufentanil (API) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Sufentanil (API) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Sufentanil (API) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Sufentanil (API) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Sufentanil (API) Sales Volume, (2025-2030) & (K Units)
Table 57. Kern Pharma Company Information
Table 58. Kern Pharma Introduction and Business Overview
Table 59. Kern Pharma Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Kern Pharma Sufentanil (API) Product Offerings
Table 61. Kern Pharma Recent Development
Table 62. Cambrex Company Information
Table 63. Cambrex Introduction and Business Overview
Table 64. Cambrex Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Cambrex Sufentanil (API) Product Offerings
Table 66. Cambrex Recent Development
Table 67. Hameln Rds Company Information
Table 68. Hameln Rds Introduction and Business Overview
Table 69. Hameln Rds Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Hameln Rds Sufentanil (API) Product Offerings
Table 71. Hameln Rds Recent Development
Table 72. Cristalia Company Information
Table 73. Cristalia Introduction and Business Overview
Table 74. Cristalia Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Cristalia Sufentanil (API) Product Offerings
Table 76. Cristalia Recent Development
Table 77. Janssen Pharmaceuticals Company Information
Table 78. Janssen Pharmaceuticals Introduction and Business Overview
Table 79. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Janssen Pharmaceuticals Sufentanil (API) Product Offerings
Table 81. Janssen Pharmaceuticals Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Sufentanil (API) Downstream Customers
Table 85. Sufentanil (API) Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Sufentanil (API) Product Picture
Figure 2. Global Sufentanil (API) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Sufentanil (API) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Sufentanil (API) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Sufentanil (API) Sales Price (2019-2030) & (US$/Unit)
Figure 6. Sufentanil (API) Report Years Considered
Figure 7. Global Sufentanil (API) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Sufentanil (API) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sufentanil (API) Revenue in 2023
Figure 10. Sufentanil (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity 98% Picture
Figure 12. Purity 99% Picture
Figure 13. Global Sufentanil (API) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Sufentanil (API) Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Sufentanil (API) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Sufentanil (API) Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Sufentanil (API) Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Injection
Figure 19. Product Picture of Capsule
Figure 20. Global Sufentanil (API) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Sufentanil (API) Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Sufentanil (API) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Sufentanil (API) Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Sufentanil (API) Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Sufentanil (API) Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Sufentanil (API) Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Sufentanil (API) Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Sufentanil (API) Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Sufentanil (API) Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Sufentanil (API) Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Sufentanil (API) Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Sufentanil (API) Sales Volume (%), (2019-2030)
Figure 37. United States Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 43. China Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 45. China Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 55. India Sufentanil (API) Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Sufentanil (API) Sales Value by Type (%), 2023 VS 2030
Figure 57. India Sufentanil (API) Sales Value by Application (%), 2023 VS 2030
Figure 58. Sufentanil (API) Industrial Chain
Figure 59. Sufentanil (API) Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
